2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
P05.062<br />
Duplication <strong>of</strong> exons 1 to 22 <strong>of</strong> the F gene: a new mechanism<br />
related to multiple copies <strong>of</strong> the intron 22 int22h sequence?<br />
C. Costa 1,2 , E. Bieth 3 , P. Boisseau 4 , S. Letourneau 1 , F. Dastot 1,2 , E. Girodon-<br />
Boulandet 1,2 , M. Goossens 1,2 ;<br />
1 AP-HP, Groupe Henri Mondor-Albert Chenevier, Laboratoire de Génétique Moléculaire,<br />
Créteil, France, 2 INSERM U841, Département de Génétique, équipe<br />
11, Université Paris 12, Créteil, France, 3 Hôpital Purpan, Laboratoire de Génétique<br />
Médicale, Toulouse, France, 4 CHU Hotel Dieu, Service de Génétique<br />
Médicale, Laboratoire de Génétique Moléculaire, Nantes, France.<br />
Interspersed repeats account for 56% <strong>of</strong> the euchromatic X chromosome<br />
sequence, compared with a genome average <strong>of</strong> 45% . Intrachromosomal<br />
duplications are estimated to account for 2 .59% <strong>of</strong> the X<br />
chromosome while interchromosomal duplications account for a very<br />
small fraction 0 .24% <strong>of</strong> the X chromosome . Among these duplications<br />
are well-described cases that are associated with genomic disorders .<br />
Some disorders may result from rearrangements involving duplicated<br />
sequences in Xq28, such as in haemophilia A . In severe haemophilia A,<br />
mutations are frequently the results <strong>of</strong> inversions between a sequence<br />
in intron 22 (int22h-1) <strong>of</strong> the F8 gene and one <strong>of</strong> two more distally<br />
located copies (int22h-2, int22h-3) described to be in the same orientation.<br />
Recently a novel finding from analysis <strong>of</strong> the DNA sequence<br />
<strong>of</strong> the human X chromosome (Ross et al, Nature 2005) has revealed<br />
that the two distal copies are in opposite orientations . Recombination<br />
should then produce deletion or duplication rather than inversion . A<br />
deletion consistent with this prediction has been reported in a family<br />
in which carrier females are affected by a high spontaneous-abortion<br />
rate in pregnancy. We report here the first case <strong>of</strong> duplication <strong>of</strong> exons<br />
1 to 22 in a carrier female in a family were none haemophiliac patient<br />
was available . The duplication was detected by MP-LC (Multiplex Liquid<br />
chromatography) and confirmed by MLPA. We believe this new<br />
rearrangement could be linked to the multiple copies <strong>of</strong> the intron 22<br />
sequences and would confirm the hypothesis that recombination could<br />
produce duplication .<br />
P05.063<br />
A comparison <strong>of</strong> quantitative real time PcR (Q-Rt-PcR) and<br />
Multiple Ligation-Dependent Probe Amplification (MLPA) for<br />
molecular diagnosis <strong>of</strong> deletions in cases <strong>of</strong> severe haemophilia<br />
A<br />
A. Venceslá, M. Baena, M. J. Barceló, J. Juan, L. Alias, M. Cornet, M.<br />
Domenech, P. Gallano, M. Baiget, E. F. Tizzano;<br />
Hospital Sant Pau, <strong>Barcelona</strong>, Spain.<br />
Haemophilia A (HA) is an X-linked bleeding disorder caused by mutations<br />
in coagulation factor VIII. The identification <strong>of</strong> HA carriers is an<br />
essential part <strong>of</strong> genetic counselling . Large rearrangements frequently<br />
occur within the F8 gene in severe haemophiliacs . These include the<br />
intron22 inversion (40-45%) the intron1 inversion (2-5%) and gross<br />
deletions encompassing one or more exons (5-10%) . Although gross<br />
deletions are readily detectable in males, the identification <strong>of</strong> heterozygosity<br />
in possible carriers <strong>of</strong> these families constitutes a challenge .<br />
To identify a deleted allele over the background <strong>of</strong> the normal allele in<br />
these carriers, we previously set up a Q-RT-PCR method employing<br />
LightCycler technology . A comparison was performed with the recently<br />
described MLPA P178 FVIII probemix that contains probes for each<br />
<strong>of</strong> the 26 exons <strong>of</strong> the F8 gene . We studied patients with deletions in<br />
exon 13, in exons 23-25, in exon 15 and in exons 1-22 . Carrier and<br />
non-carrier females from these families previously defined by quantitative<br />
or marker analysis were also tested . MLPA results in HA patients<br />
revealed the absence <strong>of</strong> the peak in the corresponding exon(s) . There<br />
was a complete correlation with results in the carrier group (one copy<br />
<strong>of</strong> the corresponding exon(s) by Q-RT-PCR and 40- 55% <strong>of</strong> reduced<br />
relative peak area in MLPA) and also in the non carrier group (two<br />
copies and 85-100% <strong>of</strong> peak area) . MLPA may be incorporated into<br />
routine molecular diagnosis <strong>of</strong> severe HA after screening <strong>of</strong> inversions .<br />
Supported by Fundació Catalana d´Hem<strong>of</strong>ilia, CIBERER, Real Fundación<br />
Victoria Eugenia.<br />
P05.064<br />
investigation <strong>of</strong> human mitochondrial DNA in iranian<br />
Hypertrophic cardiomyopathy (Hcm) patients<br />
M. Montazeri 1 , M. Houshmand 1 , E. V. Zaklyazminskaya 2 ;<br />
1 NRCGEB, Tehran, Islamic Republic <strong>of</strong> Iran, 2 Russian Research Center <strong>of</strong><br />
Medical <strong>Genetics</strong> Laboratory <strong>of</strong> DNA Research, Mosque, Russian Federation.<br />
Mitochondrial (mt) DNA defects, both deletions and tRNA point mutations,<br />
have been associated with cardiomyopathies . The aim <strong>of</strong> the<br />
study was to determine the mtDNA mutations in Hypertrophic cardiomyopathy<br />
(HCM) Iranian patients.<br />
Hypertrophic cardiomyopathy (HCM) is widely accepted as a pluricausal<br />
or multifactorial disease . Because <strong>of</strong> the linkage between energy<br />
metabolism in the mitochondria and cardiac muscle contraction,<br />
it is reasonable to assume that mitochondrial abnormalities may be<br />
responsible for some forms <strong>of</strong> HCM . We analysed the whole mitochondrial<br />
genome in a series <strong>of</strong> 31 patients with HCM for alterations<br />
and compared the findings with those <strong>of</strong> 30 control subjects. A total <strong>of</strong><br />
X sequence changes could be identified. These sequence changes<br />
were distributed among the whole mitochondrial DNA (mtDNA) . An increased<br />
number <strong>of</strong> novel missense mutations could be detected nearly<br />
in all genes encoding for protein subunits in HCM patients subjects .<br />
Four mutations were found that are unpublished . The c .4384T>C in<br />
tRNA glutamin , c .9063A>G in AtPase6 , c .2071 T>C, c .3170C>A,<br />
in noncoding MTRNA2 16S . Also 33 polymorphisms were identified<br />
in this study which had not been published in the MitoMap database .<br />
The c .16189T>C mutation in the D-loop region that is associated with<br />
susceptibility to DCM could be detected in 3% <strong>of</strong> patients as well as in<br />
0% <strong>of</strong> controls . Furthermore, mtDNA mutations may play an important<br />
role in pathogenesis <strong>of</strong> cardiac arrest which has remained unexplained<br />
for long .<br />
P05.065<br />
investigation <strong>of</strong> 69 common mutations in MYH gene in iranian<br />
population with hypertrophic cardiomyopathy<br />
M. Montazeri1 , M. Houshmand1 , M. Ghani Kakhki1 , G. Estahbanati2 , M. M.<br />
Peyghambari3 , E. V. Zaklyazminskaya4 ;<br />
1 2 nrcgeb, Tehran, Islamic Republic <strong>of</strong> Iran, Iran University <strong>of</strong> Medical Sciences<br />
Shaheed Rajaie Cardiovascular Medical Center, Tehran, Iran, Tehran, Islamic<br />
Republic <strong>of</strong> Iran, 3Iran University <strong>of</strong> Medical Sciences Shaheed Rajaie Cardiovascular<br />
Medical Center, Tehran, Iran., Tehran, Islamic Republic <strong>of</strong> Iran,<br />
4Russian Research Center <strong>of</strong> Medical <strong>Genetics</strong> Laboratory <strong>of</strong> DNA Research,<br />
Moscow, Russia., Moscow, Russian Federation.<br />
Hypertrophic cardiomyopathy is characterized by hypertrophy <strong>of</strong><br />
ventricles and intrventricular septum . Patients could develop serious<br />
complications including heart failure, arrhythmias and sudden death .<br />
Familial hypertrophic cardiomyopathy is a single gene disorder and<br />
has autosomal dominant inheritance . In this study we focused on<br />
exons 13-15 and 19-21 <strong>of</strong> MYH7 gene and introns located between<br />
them, which contain hotspots for so called “malignant mutations” that<br />
increase sudden cardiac death risk . Methods: Fifty unrelated Iranian<br />
patients with hypertrophic cardiomyopathy were selected sequentially<br />
and informed written consent was obtained from them . Exons 13-15<br />
and 19-21 <strong>of</strong> MYH7 gene and their related introns were amplified by<br />
polymerase chain reaction . Then PCR products were sequenced . Results:<br />
Mutations were detected in fourteen (28%) <strong>of</strong> the patients . We<br />
didn’t find any malignant mutation, but three mutations were found in<br />
targeted exons . One <strong>of</strong> them, A10419C (N444T) in exon 14, may be<br />
a novel mutation .<br />
P05.066<br />
A novel mitochondrial DNA tRNAile (m.4322dupc) mutation<br />
associated with idiopathic dilated cardiomyopathy<br />
S. Mahjoub 1 , D. Sternberg 2 , R. Boussaada 3 , S. Filaut 2 , F. Guemira 4 , R. Mechmech<br />
3 , C. Jardel 2 , S. Ben Arab 1 ;<br />
1 Faculté de Médecine de Tunis, Tunis, Tunisia, 2 Fédération de génétique-UF<br />
Cardio et Myogénétique , Hôpital Pitié-salpétrière, Paris, France, 3 Hôpital La<br />
Rabta, Tunis, Tunisia, 4 Hôpital Salah Azaiez, Tunis, Tunisia.<br />
Dilated cardiomyopathy (DCM) is a heart muscle disease characterized<br />
by cardiac dilatation and impaired contraction <strong>of</strong> the left ventricle<br />
(LV) or both ventricles . The age at disease onset is highly variable,<br />
ranging from early childhood to late adulthood . Only 50% <strong>of</strong> patients<br />
with DCM survive >5 years after diagnosis . Approximately 20% to 25%<br />
<strong>of</strong> cases seem to have a genetic component . DCM can be transmit-